Page last updated: 2024-08-16

thalidomide and okadaic acid

thalidomide has been researched along with okadaic acid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azuma, A; Hashimoto, Y; Hioki, E; Iwasaki, S; Kobayashi, Y; Miyachi, H	1
Aggarwal, BB; Lamothe, B; Majumdar, S	1

Other Studies

2 other study(ies) available for thalidomide and okadaic acid

Article	Year
Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production. Biochemical and biophysical research communications, 1996, Jul-16, Volume: 224, Issue:2 Topics: Carcinogens; Dose-Response Relationship, Drug; Ethers, Cyclic; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Lyngbya Toxins; Molecular Structure; Okadaic Acid; Structure-Activity Relationship; Terpenes; Tetradecanoylphorbol Acetate; Thalidomide; Thapsigargin; Tumor Necrosis Factor-alpha	1996
Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester. Journal of immunology (Baltimore, Md. : 1950), 2002, Mar-15, Volume: 168, Issue:6 Topics: Antigens, CD; Cell Line; Ceramides; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Genes, Reporter; HeLa Cells; Humans; Hydrogen Peroxide; I-kappa B Kinase; I-kappa B Proteins; Immunosuppressive Agents; Jurkat Cells; Kidney; Lipopolysaccharides; Myeloid Cells; NF-kappa B; NF-KappaB Inhibitor alpha; NF-kappaB-Inducing Kinase; Okadaic Acid; Protein Serine-Threonine Kinases; Proteins; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Tetradecanoylphorbol Acetate; Thalidomide; TNF Receptor-Associated Factor 2; Tumor Necrosis Factor-alpha; U937 Cells	2002

Article

Year

Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production.

Biochemical and biophysical research communications, 1996, Jul-16, Volume: 224, Issue:2

Topics: Carcinogens; Dose-Response Relationship, Drug; Ethers, Cyclic; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Lyngbya Toxins; Molecular Structure; Okadaic Acid; Structure-Activity Relationship; Terpenes; Tetradecanoylphorbol Acetate; Thalidomide; Thapsigargin; Tumor Necrosis Factor-alpha

1996

Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester.

Journal of immunology (Baltimore, Md. : 1950), 2002, Mar-15, Volume: 168, Issue:6

Topics: Antigens, CD; Cell Line; Ceramides; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Genes, Reporter; HeLa Cells; Humans; Hydrogen Peroxide; I-kappa B Kinase; I-kappa B Proteins; Immunosuppressive Agents; Jurkat Cells; Kidney; Lipopolysaccharides; Myeloid Cells; NF-kappa B; NF-KappaB Inhibitor alpha; NF-kappaB-Inducing Kinase; Okadaic Acid; Protein Serine-Threonine Kinases; Proteins; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Tetradecanoylphorbol Acetate; Thalidomide; TNF Receptor-Associated Factor 2; Tumor Necrosis Factor-alpha; U937 Cells

2002